Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Intestinal Perforation: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Intestinal Perforation: 1 US clinical trial tracked, none currently recruiting.

Intestinal Perforation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 1 of these trials.

Enrollment posture brief

Registry condition intestinal-perforation

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Intestinal Perforation (this)0%
Open-enrollment share among volume-matched conditions near Intestinal Perforation

Intestinal Perforation has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intestinal Perforation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intestinal Perforation is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Intestinal Perforation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

no pharmacologic treatment of the PDA Other
1 trials
pharmacologic treatment of the PDA Other
1 trials
NSAID Drug
1 trials

US sites by state

Facility locations filed on Intestinal Perforation trials. A trial with sites in several states counts in each.

Oregon 1 trials
New York 1 trials
New Jersey 1 trials
Minnesota 1 trials
Maryland 1 trials
Illinois 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intestinal Perforation page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intestinal Perforation condition card totals 1 registered trials; most-linked intervention no pharmacologic treatment of the PDA; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.